Ashwagandha Benefits: What the Evidence Shows

What Are the Proven Benefits of Ashwagandha?

Ashwagandha generates over 4,000 published research papers on PubMed, making it one of the most studied botanical supplements available. The evidence quality varies sharply by benefit category. Stress and anxiety reduction sit at the top with meta-analytic confirmation across 12 randomized controlled trials. Cortisol lowering is supported by a dedicated systematic review. Testosterone support, sleep quality, and athletic performance each have individual RCTs but lack the depth of replication seen in the stress data. The sections below grade each benefit category by evidence strength so readers can evaluate claims against published research rather than marketing language.

Does Ashwagandha Reduce Stress and Anxiety?

Akhgarjand et al. (2022) published the definitive meta-analysis in Phytotherapy Research, pooling 12 RCTs with 1,002 total participants aged 25-48 (PMID: 36017529). First, ashwagandha supplementation produced a large effect size for anxiety reduction (SMD: -1.55, 95% CI: -2.37 to -0.74, p = 0.005) compared to placebo across all included trials. Second, stress level reductions were even larger (SMD: -1.75, 95% CI: -2.29 to -1.22, p = 0.005), suggesting stress may be the primary clinical target. Third, non-linear dose-response analysis identified 300-600 mg/day as the most effective range for stress outcomes, with diminishing returns above that range.

A second meta-analysis by Arumugam et al. (2024) in Explore independently confirmed these findings (PMID: 39348746). The convergence of two independent meta-analyses from different research groups strengthens the evidence substantially. The certainty of evidence was rated low due to heterogeneity between trials, but the direction of effect was consistent across nearly all 12 included studies.

Chandrasekhar et al. (2012) published the most-cited individual RCT in Indian Journal of Psychological Medicine, enrolling 64 adults with chronic stress (PMID: 23439798). Participants took 300 mg of full-spectrum ashwagandha root extract twice daily for 60 days. Serum cortisol declined significantly (P=0.0006) in the treatment group. All three stress assessment scales, the PSS, GHQ-28, and DASS, showed significant improvement versus placebo.

Evidence grade: Strong. Two independent meta-analyses confirm the effect. Multiple individual RCTs from different research groups. Consistent direction of effect. The 300-600 mg/day dose range is well established.

Does Ashwagandha Lower Cortisol Levels?

Della Porta et al. (2023) published a systematic review in Nutrients specifically examining ashwagandha’s effect on cortisol in stressed human subjects (PMID: 38140274). First, the review confirmed that ashwagandha supplementation significantly reduced serum cortisol levels across multiple trials. Second, the effect was most pronounced in adults with high baseline cortisol due to chronic stress, occupational pressure, or anxiety. Third, the proposed mechanism involves HPA axis modulation through withanolide activity on cortisol synthesis pathways in the adrenal cortex.

Salve et al. (2019) tested two dose levels (250 mg/day and 600 mg/day) against placebo in 60 healthy adults over 8 weeks (PMID: 32021735). Both doses reduced cortisol compared to placebo, with the 600 mg/day group showing larger reductions. The cortisol-lowering effect appears to be the mechanistic foundation underlying multiple downstream benefits, including stress reduction, sleep improvement, and potentially testosterone recovery in men under chronic stress.

Evidence grade: Strong. Systematic review confirmed across multiple trials. Dose-response relationship established. Mechanism is biologically plausible through HPA axis modulation.

Does Ashwagandha Improve Sleep Quality?

Langade et al. (2019) published a double-blind RCT in Cureus with 60 patients experiencing insomnia and anxiety (PMID: 31728244). First, sleep efficiency improved from 75.6% to 83.5% in the ashwagandha group (300 mg twice daily for 10 weeks), compared to 75.1% to 79.7% in placebo. Second, sleep onset latency decreased significantly (p = 0.019) after 10 weeks of treatment. Third, Pittsburgh Sleep Quality Index scores improved across all subscales, with the most pronounced changes in sleep quality and sleep latency categories.

Fatima et al. (2024) confirmed the sleep benefits in a systematic review and meta-analysis published in Human Psychopharmacology (PMID: 39083548). Higher doses (600 mg/day or above) and longer durations (8 weeks or more) produced more consistent sleep outcomes. The proposed mechanism involves GABA-ergic activity of withanolides, though this pathway is established primarily from animal and in vitro data. Human trials confirm the sleep outcome but the exact mechanism in humans remains under investigation.

Evidence grade: Moderate to Strong. Multiple RCTs support the sleep outcome. Systematic review confirms the effect. Mechanistic pathway (GABA-ergic activity) is preclinical. Strongest results require 8 or more weeks at 600 mg/day.

Does Ashwagandha Support Testosterone Levels?

Wankhede et al. (2015) published the key RCT in the Journal of the International Society of Sports Nutrition, enrolling 57 men aged 18-50 in a resistance training program (PMID: 26609282). First, testosterone increased by 96.2 ng/dL in the ashwagandha group (600 mg/day for 8 weeks) compared to 18.0 ng/dL in placebo (p = 0.004). Second, body fat percentage decreased by 3.5% versus 1.5% in placebo (p = 0.03). Third, muscle strength on bench press increased by 46.0 kg versus 26.4 kg in placebo (p = 0.001).

Lopresti et al. (2019) examined KSM-66 at a lower dose (240 mg/day) in overweight men aged 40-70 over 8 weeks in a crossover design published in the Journal of the American Nutrition Association (PMID: 30854916). Improvements in testosterone, DHEA-S, and fatigue were observed in the ashwagandha phase compared to placebo.

Skrzypiec-Spring et al. (2025) reviewed the testosterone evidence and concluded the mechanism is most likely indirect, operating through cortisol reduction and HPA axis normalization rather than direct androgen stimulation (PMID: 38628109). This means the testosterone benefit is most relevant for men with high cortisol or chronic stress, not for men with already-optimal hormonal profiles.

Evidence grade: Moderate. Multiple RCTs show the effect but in specific populations (stressed men, resistance-trained men). The mechanism is indirect (cortisol-mediated). Generalizing to all men as a “testosterone booster” overstates the evidence.

Can Ashwagandha Improve Athletic Performance?

The Wankhede et al. (2015) trial provides the strongest athletic performance data (PMID: 26609282). First, bench press strength increased by 46.0 kg in the ashwagandha group versus 26.4 kg in placebo, a 74% greater improvement (p = 0.001). Second, leg extension strength improved by 14.5 kg versus 9.8 kg (p = 0.04). Third, muscle size at the arms increased by 8.6 cm2 compared to 5.3 cm2 in placebo (p = 0.01), and chest circumference increased by 3.3 cm versus 1.4 cm (p < 0.001). Fourth, serum creatine kinase, a marker of exercise-induced muscle damage, was significantly stabilized in the supplemented group (p = 0.03).

Additional studies have examined VO2max improvements in trained athletes at doses of 500-1,000 mg/day over 8-12 week protocols. The proposed mechanisms combine cortisol-mediated reduction in catabolic stress, improved mitochondrial efficiency, and enhanced recovery from training-induced tissue damage.

Evidence grade: Moderate. Single well-designed RCT with strong results. Additional supporting studies with small sample sizes. The recovery and adaptation benefits appear more consistent than acute performance enhancement.

Does Ashwagandha Support Cognitive Function?

Speers et al. (2021) reviewed ashwagandha’s effects on stress-related neuropsychiatric outcomes in Current Neuropharmacology (PMID: 34254920). First, multiple trials reported improvements in reaction time and cognitive task performance under stress conditions. Second, information processing speed showed measurable improvements in supplemented groups. Third, the proposed mechanisms include cortisol reduction (removing a cognitive impairment factor), antioxidant protection of neural tissue, and GABA-ergic calming effects that may improve focus.

Smith et al. (2023) tested a novel standardized ashwagandha extract (Witholytin) in adults with high stress and fatigue, reporting improvements in stress, fatigue, and cognitive clarity measures (PMID: 37740662). The cognitive benefits appear secondary to stress reduction, meaning ashwagandha improves cognition primarily by removing cortisol-mediated impairment rather than through direct nootropic action.

Evidence grade: Weak to Moderate. Studies exist but cognitive endpoints are typically secondary outcomes. Benefits appear tied to stress reduction rather than independent cognitive enhancement. More trials with cognition as the primary endpoint are needed.

Does Ashwagandha Support Male Fertility?

Mahdi et al. (2011) evaluated ashwagandha in stress-related male fertility and published results in Fertility and Sterility (PMID: 19789214). First, semen quality improved significantly in men experiencing psychological stress, with increases in sperm concentration and motility. Second, antioxidant markers in seminal plasma improved, consistent with reduced oxidative damage to spermatozoa. Third, cortisol levels decreased while testosterone levels increased in the treatment groups.

Evidence grade: Weak to Moderate. Limited to specific subpopulations (stressed infertile men). The mechanism is consistent with cortisol reduction and antioxidant activity. Replication with larger samples is needed.

What Is Ashwagandha NOT Evidence-Based For?

Several claims appear in supplement marketing without adequate clinical support. First, “hormone balance for women” is not supported by strong data, since most testosterone and hormonal studies enrolled men. Gopal et al. (2021) studied perimenopausal women and found climacteric symptom improvements (PMID: 34553463), but this is a narrow population and not generalizable. Second, “thyroid support” is based on a single RCT by Sharma et al. (2018) in subclinical hypothyroid patients (PMID: 28829155), which showed TSH and T4 changes but has not been replicated and may pose risks for people with hyperthyroid conditions. Third, anti-cancer claims derive from in vitro studies of withaferin A and have no relevance to human supplementation decisions. Fourth, “anti-aging” claims beyond stress reduction are speculative extrapolations.

What Is the Bottom Line on Ashwagandha Benefits?

Ashwagandha has an unusually strong evidence base for a botanical supplement, anchored by two independent meta-analyses confirming stress and anxiety reduction across 12 RCTs. Cortisol lowering is the mechanistic foundation that likely drives multiple downstream benefits including improved sleep, testosterone recovery in stressed men, and better cognitive performance under pressure. For adults experiencing chronic stress, ashwagandha at 300-600 mg/day of a standardized extract (KSM-66 or equivalent) represents one of the most evidence-backed natural options available. For testosterone support, the data is real but limited to stressed or training populations. For cognitive enhancement or general “wellness,” the evidence does not yet justify prioritizing ashwagandha over better-studied compounds.

Product quality and extract standardization determine whether published clinical results apply to any given product. The data above comes from standardized, branded extracts (KSM-66, Sensoril, Witholytin) at documented withanolide concentrations, not from unstandardized root powder.

For dosing information, see Ashwagandha Dosage. For safety and side effects, see Ashwagandha Side Effects.

References

1. Akhgarjand C, Asoudeh F, Bagheri A, et al. Does Ashwagandha supplementation have a beneficial effect on the management of anxiety and stress? A systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2022, 36(11):4115-4124. PMID: 36017529.
2. Arumugam V, et al. Effects of Ashwagandha (Withania Somnifera) on stress and anxiety: A systematic review and meta-analysis. Explore (NY). 2024. PMID: 39348746.
3. Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012, 34(3):255-262. PMID: 23439798.
4. Della Porta M, Maier JA, Cazzola R. Effects of Withania somnifera on Cortisol Levels in Stressed Human Subjects: A Systematic Review. Nutrients. 2023, 15(24):5053. PMID: 38140274.
5. Salve J, et al. Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-blind, Randomized, Placebo-controlled Clinical Study. Cureus. 2019, 11(12):e6466. PMID: 32021735.
6. Langade D, Kanchi S, Salve J, Debnath K, Ambegaokar D. Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study. Cureus. 2019, 11(9):e5797. PMID: 31728244.
7. Fatima K, et al. Safety and efficacy of Withania somnifera for anxiety and insomnia: Systematic review and meta-analysis. Hum Psychopharmacol. 2024, 39(5):e2903. PMID: 39083548.
8. Wankhede S, Langade D, Joshi K, Sinha SR, Bhattacharyya S. Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial. J Int Soc Sports Nutr. 2015, 12:43. PMID: 26609282.
9. Lopresti AL, Drummond PD, Smith SJ. A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha (Withania somnifera) in Aging, Overweight Males. Am J Mens Health. 2019, 13(2). PMID: 30854916.
10. Skrzypiec-Spring M, et al. Withania somnifera and Trigonella foenum-graecum as ingredients of testosterone-boosting supplements: Possible clinical implications. Adv Clin Exp Med. 2025, 34(2):287-296. PMID: 38628109.
11. Speers AB, et al. Effects of Withania somnifera (Ashwagandha) on Stress and the Stress-Related Neuropsychiatric Disorders Anxiety, Depression, and Insomnia. Curr Neuropharmacol. 2021, 19(9):1468-1495. PMID: 34254920.
12. Smith SJ, et al. Exploring the efficacy and safety of a novel standardized ashwagandha root extract (Witholytin) in adults experiencing high stress and fatigue. J Psychopharmacol. 2023, 37(12):1236-1246. PMID: 37740662.
13. Mahdi AA, et al. Withania somnifera Improves Semen Quality in Stress-Related Male Fertility. Evid Based Complement Alternat Med. 2011, 2011:576962. PMID: 19789214.
14. Gopal S, et al. Effect of an ashwagandha root extract on climacteric symptoms in women during perimenopause. J Obstet Gynaecol Res. 2021, 47(12):4414-4425. PMID: 34553463.
15. Sharma AK, Basu I, Singh S. Efficacy and Safety of Ashwagandha Root Extract in Subclinical Hypothyroid Patients: A Double-Blind, Randomized Placebo-Controlled Trial. J Altern Complement Med. 2018, 24(3):243-248. PMID: 28829155.